Physician
Gastroenterology
Dr. Wolfgang M. Korn, MD
|
|
Give Review
Wolfgang Korn works in the field of Gastroenterology. He received awards:"CMS Meaningful Use Stage 1 Certification". Wolfgang Korn is a published doctor and has 26 publications published. The lastest was: 'A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.' Wolfgang Korn accepts Medicare.
Publications
- (90)Y Glass Microspheres for the Treatment of Unresectable Metastatic Liver Disease from Chemotherapy-Refractory Gastrointestinal Cancers: A Pilot Study.
- A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal Cancer.
- Subtype Specific MEK - PI3 Kinase Feedback as a Therapeutic Target in Pancreatic AdenoCarcinoma.
- Gastric Cancer, Version 2.2013.
- Temsirolimus combined with sorafenib in hepatocellular Carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
- A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid Malignancies.
- Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of Carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conj...
- Prevention and management of early esophageal Cancer.
- Esophageal erosion 9 years after anterior cervical plate implantation.
- Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal Liver.
- Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).
- Fluid biopsy in patients with metastatic prostate, pancreatic and breast Cancers.
- Characterization of circulating tumor cell aggregates identified in patients with epithelial Tumors.
- Moving toward an understanding of the metastatic process in hepatocellular Carcinoma.
- Chromosome arm 20q gains and other genomic alterations in colorectal Cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in s...
- A dynamical systems model for combinatorial Cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.
- Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenoCarcinoma.
- RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.
- Disruption of 3D Tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor.
- Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast Cancer cells to MEK inhibition.
- A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic Cancer.
- ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor.
- Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal Cancer correlates with tumor differentiation.
- Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in Cancer cells.
- A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor Malignancies.
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1235187055 | |
| NPPES Provider LastName | KORN | |
| NPPES Provider FirstName | WOLFGANG | |
| NPPES Provider ZIPCode | 941153465 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 52.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235187055 |
| Last Name Of The Provider | KORN |
| First Name Of The Provider | WOLFGANG |
| View All |
Similar Doctors
|
|
Dr. Harvey D. Watts, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarita Dubey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel N. Mannis, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis D. Shen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven C. White, MD |